Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension | 22 | 2014 | 8455 | 1.130 |
Why?
|
| Deep Brain Stimulation | 4 | 2020 | 746 | 0.860 |
Why?
|
| Ventral Thalamic Nuclei | 2 | 2017 | 41 | 0.740 |
Why?
|
| Foramen Ovale, Patent | 1 | 2021 | 223 | 0.620 |
Why?
|
| Subthalamic Nucleus | 2 | 2017 | 185 | 0.610 |
Why?
|
| Sodium, Dietary | 3 | 2014 | 418 | 0.550 |
Why?
|
| Blood Pressure Determination | 10 | 2011 | 632 | 0.530 |
Why?
|
| Essential Tremor | 1 | 2017 | 130 | 0.500 |
Why?
|
| Awareness | 2 | 2010 | 639 | 0.500 |
Why?
|
| Magnesium Deficiency | 1 | 2014 | 47 | 0.480 |
Why?
|
| Eye Movements | 1 | 2017 | 506 | 0.460 |
Why?
|
| Magnesium | 1 | 2014 | 813 | 0.380 |
Why?
|
| Action Potentials | 2 | 2017 | 1814 | 0.370 |
Why?
|
| Health Promotion | 7 | 2014 | 2194 | 0.340 |
Why?
|
| Catheter Ablation | 1 | 2022 | 2746 | 0.330 |
Why?
|
| Sodium | 1 | 2014 | 1627 | 0.330 |
Why?
|
| Pulmonary Embolism | 1 | 2021 | 2370 | 0.310 |
Why?
|
| Antihypertensive Agents | 6 | 2011 | 2043 | 0.310 |
Why?
|
| Parkinson Disease | 2 | 2017 | 2774 | 0.280 |
Why?
|
| Canada | 12 | 2011 | 2061 | 0.250 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5171 | 0.230 |
Why?
|
| Blood Pressure | 5 | 2014 | 8541 | 0.230 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 2211 | 0.220 |
Why?
|
| Life Style | 5 | 2010 | 3824 | 0.210 |
Why?
|
| Cholecystitis, Acute | 1 | 2022 | 70 | 0.200 |
Why?
|
| Contrast Media | 1 | 2015 | 5295 | 0.200 |
Why?
|
| Self Care | 1 | 2007 | 786 | 0.200 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 4029 | 0.200 |
Why?
|
| Embolectomy | 1 | 2021 | 120 | 0.180 |
Why?
|
| Gallstones | 1 | 2022 | 286 | 0.180 |
Why?
|
| Liver | 1 | 2015 | 7470 | 0.170 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 4249 | 0.170 |
Why?
|
| Body Weight | 1 | 2010 | 4664 | 0.170 |
Why?
|
| India | 3 | 2014 | 2187 | 0.170 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 3 | 2010 | 236 | 0.160 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 13019 | 0.150 |
Why?
|
| Cardiovascular Diseases | 8 | 2014 | 15108 | 0.150 |
Why?
|
| Catheters | 1 | 2021 | 422 | 0.150 |
Why?
|
| Meta-Analysis as Topic | 1 | 2022 | 1342 | 0.150 |
Why?
|
| Cranial Nerves | 1 | 2017 | 101 | 0.150 |
Why?
|
| International Cooperation | 2 | 2003 | 1421 | 0.150 |
Why?
|
| Food Industry | 2 | 2014 | 68 | 0.140 |
Why?
|
| Disease Outbreaks | 1 | 2006 | 1768 | 0.140 |
Why?
|
| Electrodes, Implanted | 2 | 2020 | 824 | 0.140 |
Why?
|
| Thrombectomy | 1 | 2021 | 679 | 0.130 |
Why?
|
| Health Policy | 4 | 2014 | 2657 | 0.130 |
Why?
|
| Biomedical Research | 2 | 2013 | 3306 | 0.110 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2014 | 120 | 0.110 |
Why?
|
| Humans | 41 | 2022 | 742088 | 0.110 |
Why?
|
| Urinalysis | 1 | 2014 | 369 | 0.100 |
Why?
|
| Electric Stimulation Therapy | 1 | 2017 | 605 | 0.100 |
Why?
|
| Thrombolytic Therapy | 1 | 2021 | 2161 | 0.100 |
Why?
|
| Health Personnel | 2 | 2004 | 3210 | 0.100 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2012 | 92 | 0.100 |
Why?
|
| Head | 1 | 2017 | 878 | 0.100 |
Why?
|
| Body Composition | 4 | 2012 | 2400 | 0.100 |
Why?
|
| Fast Foods | 1 | 2013 | 197 | 0.090 |
Why?
|
| Diet, Sodium-Restricted | 2 | 2014 | 287 | 0.090 |
Why?
|
| Disease Management | 1 | 2021 | 2450 | 0.090 |
Why?
|
| Middle Aged | 16 | 2020 | 213127 | 0.090 |
Why?
|
| Risk Assessment | 8 | 2011 | 23320 | 0.090 |
Why?
|
| Adult | 14 | 2022 | 213712 | 0.090 |
Why?
|
| Policy Making | 1 | 2013 | 554 | 0.080 |
Why?
|
| Exercise | 1 | 2005 | 5611 | 0.080 |
Why?
|
| Mental Health | 2 | 2013 | 2997 | 0.080 |
Why?
|
| Creatinine | 1 | 2014 | 1916 | 0.080 |
Why?
|
| Aged | 13 | 2020 | 162944 | 0.080 |
Why?
|
| Turkey | 1 | 2008 | 237 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 35342 | 0.080 |
Why?
|
| Male | 18 | 2020 | 349538 | 0.080 |
Why?
|
| Pain Measurement | 1 | 2017 | 3418 | 0.080 |
Why?
|
| Delivery of Health Care | 2 | 2013 | 5304 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2012 | 11695 | 0.070 |
Why?
|
| Female | 18 | 2020 | 379592 | 0.070 |
Why?
|
| Intra-Abdominal Fat | 1 | 2012 | 591 | 0.070 |
Why?
|
| Education, Medical, Continuing | 2 | 2009 | 839 | 0.070 |
Why?
|
| Body Mass Index | 4 | 2014 | 12695 | 0.070 |
Why?
|
| Anniversaries and Special Events | 1 | 2006 | 89 | 0.070 |
Why?
|
| Anticoagulants | 1 | 2020 | 4595 | 0.060 |
Why?
|
| Decision Trees | 1 | 2007 | 506 | 0.060 |
Why?
|
| Migraine Disorders | 1 | 2017 | 1620 | 0.060 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2013 | 941 | 0.060 |
Why?
|
| Information Science | 1 | 2003 | 4 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 3 | 2013 | 7276 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 9185 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 57683 | 0.060 |
Why?
|
| Mental Disorders | 2 | 2013 | 6587 | 0.060 |
Why?
|
| Social Responsibility | 1 | 2006 | 389 | 0.060 |
Why?
|
| Diet, Fat-Restricted | 1 | 2005 | 317 | 0.060 |
Why?
|
| Residence Characteristics | 1 | 2013 | 2049 | 0.050 |
Why?
|
| Total Quality Management | 1 | 2004 | 274 | 0.050 |
Why?
|
| Risk Factors | 7 | 2014 | 72145 | 0.050 |
Why?
|
| Morbidity | 1 | 2008 | 1767 | 0.050 |
Why?
|
| Circadian Rhythm | 1 | 2014 | 2623 | 0.050 |
Why?
|
| Treatment Outcome | 6 | 2022 | 62966 | 0.050 |
Why?
|
| Emigrants and Immigrants | 1 | 2009 | 519 | 0.050 |
Why?
|
| Cultural Diversity | 1 | 2006 | 358 | 0.050 |
Why?
|
| Office Visits | 1 | 2006 | 598 | 0.050 |
Why?
|
| Mental Health Services | 1 | 2013 | 1643 | 0.050 |
Why?
|
| Information Services | 1 | 2003 | 244 | 0.050 |
Why?
|
| Cooperative Behavior | 2 | 2013 | 1503 | 0.050 |
Why?
|
| Knowledge | 1 | 2003 | 179 | 0.050 |
Why?
|
| Attitude to Health | 1 | 2010 | 2051 | 0.050 |
Why?
|
| Education | 1 | 2004 | 543 | 0.050 |
Why?
|
| Combined Modality Therapy | 3 | 2009 | 8621 | 0.050 |
Why?
|
| Feeding Behavior | 1 | 2013 | 3187 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2005 | 2295 | 0.050 |
Why?
|
| Patient Education as Topic | 2 | 2007 | 2275 | 0.040 |
Why?
|
| Severity of Illness Index | 3 | 2009 | 15530 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 2011 | 6483 | 0.040 |
Why?
|
| Age Distribution | 1 | 2005 | 2900 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2008 | 2485 | 0.040 |
Why?
|
| Prevalence | 2 | 2006 | 15194 | 0.040 |
Why?
|
| Obesity | 2 | 2012 | 12705 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18006 | 0.040 |
Why?
|
| Lasers | 1 | 2022 | 952 | 0.040 |
Why?
|
| Diffusion of Innovation | 1 | 2003 | 725 | 0.040 |
Why?
|
| Age Factors | 1 | 2014 | 18355 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 19862 | 0.040 |
Why?
|
| British Columbia | 2 | 2007 | 241 | 0.030 |
Why?
|
| Health Services Research | 1 | 2004 | 1834 | 0.030 |
Why?
|
| Rodentia | 1 | 2017 | 262 | 0.030 |
Why?
|
| Diet | 1 | 2014 | 7923 | 0.030 |
Why?
|
| Physical Stimulation | 1 | 2017 | 525 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2006 | 2616 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2007 | 3278 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2005 | 2680 | 0.030 |
Why?
|
| International Agencies | 1 | 2014 | 240 | 0.030 |
Why?
|
| Mass Screening | 2 | 2006 | 5238 | 0.030 |
Why?
|
| Public Health | 1 | 2006 | 2594 | 0.030 |
Why?
|
| Organizations | 1 | 2014 | 170 | 0.030 |
Why?
|
| Government | 1 | 2014 | 165 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2005 | 3957 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2009 | 3428 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2017 | 53187 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2005 | 10248 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2022 | 5062 | 0.030 |
Why?
|
| Societies, Medical | 2 | 2014 | 3740 | 0.030 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2014 | 281 | 0.030 |
Why?
|
| Social Class | 2 | 2012 | 1995 | 0.020 |
Why?
|
| Developing Countries | 1 | 2003 | 2789 | 0.020 |
Why?
|
| Organizational Objectives | 1 | 2013 | 438 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2003 | 3611 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2005 | 4229 | 0.020 |
Why?
|
| Restaurants | 1 | 2013 | 236 | 0.020 |
Why?
|
| Government Regulation | 1 | 2014 | 522 | 0.020 |
Why?
|
| Public Policy | 1 | 2014 | 572 | 0.020 |
Why?
|
| Food Preferences | 1 | 2013 | 399 | 0.020 |
Why?
|
| Prognosis | 2 | 2009 | 29010 | 0.020 |
Why?
|
| Diuretics | 1 | 2011 | 591 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2011 | 689 | 0.020 |
Why?
|
| World Health Organization | 1 | 2014 | 1317 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2022 | 77098 | 0.020 |
Why?
|
| Incidence | 1 | 2005 | 20928 | 0.020 |
Why?
|
| Asia | 1 | 2009 | 607 | 0.020 |
Why?
|
| Viscera | 1 | 2007 | 139 | 0.020 |
Why?
|
| Comorbidity | 2 | 2013 | 10372 | 0.020 |
Why?
|
| Program Development | 1 | 2013 | 1314 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 8300 | 0.020 |
Why?
|
| Quality of Health Care | 2 | 2013 | 4369 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2012 | 1726 | 0.020 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2011 | 923 | 0.020 |
Why?
|
| Risk Management | 1 | 2009 | 571 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2012 | 1813 | 0.020 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2011 | 1517 | 0.020 |
Why?
|
| Health Education | 1 | 2011 | 1053 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 2009 | 952 | 0.020 |
Why?
|
| Triglycerides | 1 | 2012 | 2450 | 0.010 |
Why?
|
| Pheochromocytoma | 1 | 2006 | 337 | 0.010 |
Why?
|
| Health Care Reform | 1 | 2013 | 1261 | 0.010 |
Why?
|
| Hyperaldosteronism | 1 | 2006 | 239 | 0.010 |
Why?
|
| Clinical Competence | 2 | 2009 | 4681 | 0.010 |
Why?
|
| China | 1 | 2009 | 2246 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2017 | 9144 | 0.010 |
Why?
|
| Demography | 1 | 2007 | 1650 | 0.010 |
Why?
|
| Europe | 1 | 2009 | 3339 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2017 | 40450 | 0.010 |
Why?
|
| Advisory Committees | 1 | 2006 | 773 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2013 | 2527 | 0.010 |
Why?
|
| Rats | 1 | 2017 | 24265 | 0.010 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2003 | 307 | 0.010 |
Why?
|
| Lipids | 1 | 2012 | 3302 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 7770 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2009 | 2266 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2020 | 15244 | 0.010 |
Why?
|
| Neurons | 1 | 2017 | 9325 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2012 | 6249 | 0.010 |
Why?
|
| Genotype | 1 | 2012 | 12946 | 0.010 |
Why?
|
| Medical Informatics | 1 | 2003 | 742 | 0.010 |
Why?
|
| Risk | 1 | 2009 | 9679 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2013 | 5133 | 0.010 |
Why?
|
| Patient Selection | 1 | 2007 | 4214 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2011 | 4551 | 0.010 |
Why?
|
| United States | 1 | 2003 | 69693 | 0.010 |
Why?
|
| Phenotype | 1 | 2012 | 16331 | 0.010 |
Why?
|
| Forecasting | 1 | 2003 | 2948 | 0.010 |
Why?
|
| Echocardiography | 1 | 2006 | 5097 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 12958 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 9941 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 24913 | 0.010 |
Why?
|
| Communication | 1 | 2003 | 3728 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2009 | 39004 | 0.000 |
Why?
|
| Animals | 1 | 2017 | 168561 | 0.000 |
Why?
|
Concepts
(203)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(3)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_